Triple-Gene Announces Presentation at Upcoming Biotech Showcase Investor Conference

GERMANTOWN, Md., Jan. 9, 2020 /PRNewswire/ — Triple-Gene LLC, a clinical stage cardiovascular gene therapy company, today announced that Thomas D. Reed, PhD, Co-Founder, will present at the Biotech Showcase on January 15th, 2020 at 11:30AM PT at the Hilton San Francisco Union Square….

About the Author

has written 41834 stories on this site.

Copyright © 2010 Business and Corporate News.